BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Signet Accel Appoints New Vice President of Marketing Amid Growth

  Software and services company Signet Accel announced today that Carolyn Ewing-Turner joined the company as Vice President of Marketing.

  November 9, 2017

   · 

  3 min read
• Pharm Country

  Johnson & Johnson Vision Announces TearScience LipiScan and LipiFlow Now Available in More Than 800 Eye Care Practices to Image Meibomian Glands and Treat Meibomian Gland Dysfunction

  Meibomian Gland Dysfunction (MGD) is a primary cause of dry eye disease, which impacts more than 340 million people globally.

  November 9, 2017

   · 

  3 min read
• Business

  Perrigo Company Reports Third Quarter 2017 Financial Results

  Delivered third quarter 2017 GAAP (“reported”) net sales of $1.2 billion, reported net income of $45 million and reported diluted earnings per share (“EPS”) of $0.31 compared to a loss per share of $11.10 last year.

  November 9, 2017

   · 

  62 min read
• 

  FDA

  FDA Green Lights Neusoft Medical’s NeuViz Prime CT Scanner

  The latest advance in more than 20 years of continual CT innovation.

  November 9, 2017

   · 

  2 min read
• Business

  Innovus Pharma Announces Agreement With ACON Laboratories

  ACON Labs is a San Diego-based diagnostic product manufacturer who will supply Innovus Pharma with its FDA cleared Urinary Tract Infection test strips.

  November 9, 2017

   · 

  7 min read
• Biotech Beach

  Nexalin Technology Demonstrates Success in the Treatment of Depression

  Nexalin Technology is pleased to announce the initiation of clinical trials designed by the University of Pennsylvania to investigate the effectiveness of the Nexalin transcranial stimulation (TACS) for major depressive disorder.

  November 9, 2017

   · 

  4 min read
• Business

  Knight Reports Third Quarter 2017 Results

  As at September 30, 2017, Knight had over $760,000 in cash, cash equivalents and marketable securities and 142,772,805 common shares outstanding.

  November 9, 2017

   · 

  18 min read
• Business

  Concert Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Company Update

  Cash, cash equivalents and investments as of September 30, 2017, totaled $207.1 million as compared to $103.4 million as of June 30, 2017.

  November 9, 2017

   · 

  8 min read
• Alkermes Reveals Recipients of the 2nd Annual Competitive Grants Program to Support Those Affected by Mental Health and Substance Use Disorders

  Alkermes announced the company awarded $1 million in grants to national and local non-profit community organizations for the implementation of innovative, high-impact and replicable programs designed to support people affected by mental health and substance use disorders.

  November 9, 2017

   · 

  3 min read
• Business

  Aldeyra Therapeutics Announces Third Quarter 2017 Financial Results

  For the third quarter, Aldeyra reported a net loss of approximately $5.0 million, compared to a net loss of approximately $4.8 million for the quarter ended September 30, 2016.

  November 9, 2017

   · 

  20 min read